Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Malignant Melanoma

  Free Subscription


2 Ann Surg Oncol
1 Br J Dermatol
1 Cancer Res
1 J Invest Dermatol
2 Lancet
2 Lancet Oncol
1 Ophthalmology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Surg Oncol

  1. HAYWOOD S, Garioch J, Ramaiya A, Moncrieff M, et al
    Quantitative and Spatial Analysis of CD8+/PD-1 Tumor-Infiltrating Lymphocytes as a Predictive Biomarker for Clinical Response of Melanoma In-Transit Metastases to Topical Immunotherapy.
    Ann Surg Oncol. 2020 Jun 15. pii: 10.1245/s10434-020-08713.
    PubMed         Abstract available

  2. MORRISON S, Han D
    ASO Author Reflections: Sentinel Lymph Node Biopsy is Prognostic in the Thickest Melanoma Cases and Should be Performed for Thick Melanomas.
    Ann Surg Oncol. 2020 Jun 12. pii: 10.1245/s10434-020-08725.

    Br J Dermatol

  3. HOLLESTEIN LM, Nijsten T
    Survival is excellent for most patients with thin melanoma, but patients may die from thin melanoma.
    Br J Dermatol. 2020 Jun 15. doi: 10.1111/bjd.19208.

    Cancer Res

  4. SACHDEVA R, Wu M, Smiljanic S, Kaskun O, et al
    ID1 Is Critical for Tumorigenesis and Regulates Chemoresistance in Glioblastoma.
    Cancer Res. 2019 Jul 10. pii: 0008-5472.CAN-18-1357.
    PubMed         Abstract available

    J Invest Dermatol

  5. TAKABE P, Karna R, Rauhala L, Tammi M, et al
    Melanocyte hyaluronan coat fragmentation enhances the UVB-induced TLR-4 receptor signaling and expression of proinflammatory mediators IL-6, IL-8, CXCL-1 and CXCL-10 via NF-kappaB activation.
    J Invest Dermatol. 2019 Mar 29. pii: S0022-202X(19)31391.
    PubMed         Abstract available


  6. RIBAS A
    Triple therapy for BRAF(V600)-mutated melanoma.
    Lancet. 2020;395:1814-1815.

  7. GUTZMER R, Stroyakovskiy D, Gogas H, Robert C, et al
    Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF(V600) mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial.
    Lancet. 2020;395:1835-1844.
    PubMed         Abstract available

    Lancet Oncol

  8. TAWBI H
    A promising start for checkpoint inhibitors in childhood malignancies.
    Lancet Oncol. 2020;21:13-14.

  9. NORONHA C, Rocha L
    Meningeal melanocytosis: a challenging diagnosis.
    Lancet Oncol. 2019;20:e343.


  10. VAN IPENBURG JA, Gillis Ing AJM, Dorssers LCJ, van den Bosch QCC, et al
    MicroRNA Profiling in Benign and Malignant Conjunctival Melanocytic Lesions.
    Ophthalmology. 2019 Oct 12. pii: S0161-6420(19)32142.

    PLoS One

  11. BUSS LA, Ang AD, Hock B, Robinson BA, et al
    Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.
    PLoS One. 2020;15:e0229290.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.